MYnd Analytics Directed Therapy in Depression
Status unconfirmed · Phase 4
Conditions studied: Depression
In brief
The MYnd Analytics PEER Online strategy utilizes EEG diagnostics to direct patients with psychiatric illnesses to the best medication treatments. This trial will evaluate patients with a diagnosis of depression who will either receive (1) PEER Online directed therapy or (2) conventional treatment without EEG guidance and will compare 6 month clinical and economic outcomes between these groups.
Key facts
- Study ID
- NCT03328052
- Run by
- Cota Inc.
- People needed
- 600
- Starts
- 2017-10-01
- Expected to finish
- 2020-10-01
- Last updated by the study team
- 2017-11-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a clinical diagnosis of depression who in the judgement of their physician require medication management may be eligible for enrollment. A score of 10 or more on the PHQ-9 instrument will be required for enrollment.
- Some practices utilize the PHQ-2 and PHQ-9 are part of routine screening for depression. If the tests are performed routinely, they do not need to be repeated for study eligibility, and may be performed prior to informed consent for this study. If, however, the PHQ-9 is not routinely performed, informed consent must be performed prior to administration. Patients with a score below 10 will be considered screen failures and will not be enrolled or offered the MYnd testing.
- Patients with non-psychotic comorbid conditions may be included.
- Patients must be either medication treatment naïve for behavioral illnesses or have no active medication treatments for at least 1 month prior to enrollment. Prohibited medications at the time of enrollment will include stimulants, benzodiazepines and THC. Prior therapy with these agents is permitted with a washout of >30 days.
- Patients must have private medical insurance coverage through Horizon Blue Cross Blue Shield. This is limited to insured commercial members, including HMO, and excluding, for the avoidance of doubt, members of self-insured customers or Medicare or Medicaid programs.
You may not qualify if…
- Diagnosis of a psychotic disorder.
- History of, or current, open head brain trauma. Candidates with any metal, shrapnel or other similar objects in the head that could affect the QEEG
- History of: craniotomy, cerebral metastases, cerebrovascular accident; current diagnosis of seizure disorder, schizophrenia, schizo-affective disorder, dementia, mental retardation, or major depression with psychotic features; or use of depot neuroleptics in last 12 months.
- Uncontrolled thyroid disorders.
- Known pregnancy and/or lactation, or intent to become pregnant during this study.
- Chronic or acute pain requiring prescription pain medication(s) (narcotic or synthetic narcotic)
- Participation in any other therapeutic drug study within 60 days preceding inclusion.
Where it is running
- Hackensack Meridian Health Network — Brick, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Brick, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Hackensack, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Hackensack, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Holmdel, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Jackson, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Lodi, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Lodi, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Neptune City, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Oakhurst, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Old Bridge, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Paramus, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Point Pleasant, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Saddle Brook, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Tinton Falls, New Jersey, United States (enrolling)
- Hackensack Meridian Health Network — Toms River, New Jersey, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.